Double-negative T cells during HIV/SIV infections: Potential pinch hitters in the T-cell lineup

Current Opinion in HIV and AIDS

Volumn 7, Issue 2, 2012, Pages 164-171

  Sundaravaradan, Vasudha ^a   Mir, Kiran D ^b   Sodora, Donald L ^a  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

double negative T cells; helper T cells; natural hosts; SIV HIV infection; T regulatory cells

Indexed keywords

T LYMPHOCYTE RECEPTOR;

AUTOIMMUNITY; CD3+ CD4- CD8- T LYMPHOCYTE%; CD4+ T LYMPHOCYTE; CELL FUNCTION; HAPLORHINI; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD3; CERCOCEBUS ATYS; COHORT STUDIES; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; MACACA MULATTA; MONKEY DISEASES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 84857369300     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3283504a66     Document Type: Review

References (93)

1. Brenchley JM, Silvestri G, Douek DC. Nonprogressive and progressive primate immunodeficiency lentivirus infections. Immunity 2010; 32:737-742.
2. Mir KD, Gasper MA, Sundaravaradan V, Sodora DL. SIV infection in natural hosts: resolution of immune activation during the acute-to-chronic transition phase. Microbes Infect 2011; 13:14-24.
3. Pandrea I, Silvestri G, Apetrei C. AIDS in African nonhuman primate hosts of SIVs: a new paradigm of SIV infection. Curr HIV Res 2009; 7:57-72.
4. Pandrea I, Sodora DL, Silvestri G, Apetrei C. Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts. Trends Immunol 2008; 29:419-428.
5. Silvestri G, Paiardini M, Pandrea I, et al. Understanding the benign nature of SIV infection in natural hosts. J Clin Invest 2007; 117:3148-3154. (Pubitemid 350096967)
6. Sodora DL, Allan JS, Apetrei C, et al. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 2009; 15:861-865.
7. Sodora DL, Silvestri G. Immune activation and AIDS pathogenesis. AIDS 2008; 22:439-446. (Pubitemid 351317285)
8. D'Acquisto F, Crompton T. CD3CD4-CD8- (double negative) T cells: saviours or villains of the immune response? Biochem Pharmacol 2011; 82:333-340.
9. Fischer K, Voelkl S, Heymann J, et al. Isolation and characterization of human antigen-specific TCRalpha beta CD4-CD8- double-negative regulatory T cells. Blood 2005; 105:2828-2835. (Pubitemid 40446276)
10. Thomson CW, Lee BP, Zhang L. Double-negative regulatory T cells: nonconventional regulators. Immunol Res 2006; 35:163-178. (Pubitemid 44547511)
11. Zhang ZX, Young K, Zhang L. CD3CD4-CD8- alphabeta-TCR T cell as immune regulatory cell. J Mol Med 2001; 79:419-427.
12. Vinton C, Klatt NR, Harris LD, et al. CD4-like immunological function by CD4- T cells in multiple natural hosts of simian immunodeficiency virus. J Virol 2011; 85:8702-8708.
13. Bernardo I, Mancebo E, Aguilo I, et al. Phenotypic and functional evaluation of CD3CD4-CD8- T cells in human CD8 immunodeficiency. Haematologica 2011; 96:1195-1203.
14. Bleesing JJ, Brown MR, Novicio C, et al. A composite picture of TcRabCD4-CD8-T cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome. Clin Immunol 2002; 104:21-30.
15. Cowley SC, Meierovics AI, Frelinger JA, et al. Lung CD4-CD8- doublenegative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain. J Immunol 2010; 184:5791-5801. This research clearly demonstrates the role of double-negative T cells in the lung to control bacterial infection by producing T cells cytokines.
16. Ford McIntyre MS, Gao JF, Li X, et al. Consequences of double negative regulatory T cell and antigen presenting cell interaction on immune response suppression. Int Immunopharmacol 2010; 11:597-603. Potential of double-negative T cells in interactions with stimulated allogeneic antigen-presenting cells and B cells demonstrating regulatory function.
17. Margolick JB, Carey V, Munoz A, et al. Development of antibodies to HIV-1 is associated with an increase in circulating CD3CD4-CD8- lymphocytes. Clin Immunol Immunopathol 1989; 51:348-361. (Pubitemid 19149842)
18. Matsumoto M, Yasukawa M, Inatsuki A, Kobayashi Y. Human double-negative (CD4-CD8-) T cells bearing alpha beta T cell receptor possess both helper and cytotoxic activities. Clin Exp Immunol 1991; 85:525-530.
19. Milush JM, Mir KD, Sundaravaradan V, et al. Lack of clinical AIDS in SIVinfected sooty mangabeys with significant CD4 T cell loss is associated with double-negative T cells. J Clin Invest 2011; 121:1102-1110. This article describes the potential of double-negative T cells to compensate for CD4 T cell loss during SIV infection of natural hosts in 5-year longitudinal studies. These cells are shown to have CD4-like function and repond to SIV antigens and influenza vaccination in mangabeys with extremely low CD4 T cells.
20. Patel SS, Wacholtz MC, Duby AD, et al. Analysis of the functional capabilities of CD3CD4-CD8- and CD3CD4CD8 human T cell clones. J Immunol 1989; 143:1108-1117.
21. Villani FN, Rocha MO, Nunes Mdo C, et al. Trypanosoma cruzi-induced activation of functionally distinct alphabeta and gammadelta CD4- CD8- T cells in individuals with polar forms of Chagas' disease. Infect Immun 2010; 78:4421-4430. The role of different double-negative T-cell subsets responsible for controlling disease progression in parasitic infection.
22. Young KJ, DuTemple B, Zhang Z, et al. CD4-CD8-regulatory T cells implicated in preventing graft-versus-host and promoting graft-versus-leukemia responses. Transplant Proc 2001; 33:1762-1763. (Pubitemid 32238055)
23. Kadena T, Matsuzaki G, Fujise S, et al. TCRabCD4-CD8-T cells differentiate extrathymically in an lck-independent manner and participate in early response against Listeria monocytogenes infection through interferon-gamma production. Immunology 1997; 91:511-519. (Pubitemid 27312331)
24. Voelkl S, Gary R, Mackensen A. Characterization of the immunoregulatory function of human TCRabCD4-CD8- double-negative T cells. Eur J Immunol 2011; 41:739-748. This study demonstrates the ability of double-negative T cells in humans to limit CD4 and CD8 proliferation in a contact dependant manner indicating regulatory function of these cells.
25. Duncan B, Nazarov-Stoica C, Surls J, et al. Double negative (CD34-8-) TCR alphabeta splenic cells from young NOD mice provide long-lasting protection against type 1 diabetes. PLoS One 2010; 5:e11427.
26. Gao JF, McIntyre MS, Juvet SC, et al. Regulation of antigen-expressing dendritic cells by double negative regulatory T cells. Eur J Immunol 2011; 41:2699-2708.
27. Priatel JJ, Utting O, Teh HS. TCR/self-antigen interactions drive doublenegative T cell peripheral expansion and differentiation into suppressor cells. J Immunol 2001; 167:6188-6194. (Pubitemid 33081546)
28. Hsu AP, Dowdell KC, Davis J, et al. Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal transducing death domain: molecular mechanisms and clinical penetrance. Genet Med 2011. Potential of antigen-specific memory double-negative T cells to undergo homeostatic proliferation to regulate CD8 proliferation by Fas-FasL cytolytic mechanism.
29. Madkaikar M, Mhatre S, Gupta M, Ghosh K. Advances in autoimmune lymphoproliferative syndromes. Eur J Haematol 2011; 87:1-9.
30. Magerus-Chatinet A, Neven B, Stolzenberg MC, et al. Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation. J Clin Invest 2011; 121:106-112.
31. Alarcon B, van Santen HM. Two receptors, two kinases, and T cell lineage determination. Sci Signal 2010; 3:e11.
32. Koch U, Radtke F. Mechanisms of T cell development and transformation. Annu Rev Cell Dev Biol 2011; 27:539-562.
33. Singer A, Adoro S, Park JH. Lineage fate and intense debate: myths, models and mechanisms of CD4-versus CD8-lineage choice. Nat Rev Immunol 2008; 8:788-801.
34. Mixter PF, Russell JQ, Morrissette GJ, et al. A model for the origin of TCRalphabeta CD4-CD8-B220 cells based on high affinity TCR signals. J Immunol 1999; 162:5747-5756.
35. Wang R, Wang-Zhu Y, Grey H. Interactions between double positive thymocytes and high affinity ligands presented by cortical epithelial cells generate double negative thymocytes with T cell regulatory activity. Proc Natl Acad Sci U S A 2002; 99:2181-2186. (Pubitemid 34169035)
36. Illum N, Ralfkiaer E, Pallesen G, Geisler C. Phenotypical and functional characterization of double-negative (CD4-CD8-) alpha beta T-cell receptor positive cells from an immunodeficient patient. Scand J Immunol 1991; 34:635-645.
37. Brooks EG, Balk SP, Aupeix K, et al. Human T-cell receptor (TCR) alpha/beta CD4-CD8- T cells express oligoclonal TCRs, share junctional motifs across TCR V beta-gene families, and phenotypically resemble memory T cells. Proc Natl Acad Sci U S A 1993; 90:11787-11791. (Pubitemid 24008724)
38. Beaumier CM, Harris LD, Goldstein S, et al. CD4 downregulation by memory CD4 T cells in vivo renders African green monkeys resistant to progressive SIVagm infection. Nat Med 2009; 15:879-885.
39. Doyle C, Strominger JL. Interaction between CD4 and class IIMHCmolecules mediates cell adhesion. Nature 1987; 330:256-259. (Pubitemid 18006419)
40. Marrack P, Endres R, Shimonkevitz R, et al. The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product. J Exp Med 1983; 158:1077-1091. (Pubitemid 13013420)
41. Barber EK, Dasgupta JD, Schlossman SF, et al. The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex. Proc Natl Acad Sci U S A 1989; 86:3277-3281. (Pubitemid 19129594)
42. Salmond RJ, Filby A, Qureshi I, et al. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol Rev 2009; 228:9-22.
43. Yudushkin IA, Vale RD. Imaging T-cell receptor activation reveals accumulation of tyrosine-phosphorylated CD3zeta in the endosomal compartment. Proc Natl Acad Sci U S A 2010; 107:22128-22133.
44. Nel AE. T-cell activation through the antigen receptor. Part 1: Signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J Allergy Clin Immunol 2002; 109:758-770. (Pubitemid 34499506)
45. Killeen N, Davis CB, Chu K, et al. CD4 function in thymocyte differentiation and T cell activation. Philos Trans R Soc Lond B Biol Sci 1993; 342:25-34.
46. Wang Q, Malherbe L, Zhang D, et al. CD4 promotes breadth in the TCR repertoire. J Immunol 2001; 167:4311-4320. (Pubitemid 32954306)
47. Denny MF, Patai B, Straus DB. Differential T-cell antigen receptor signaling mediated by the Src family kinases Lck and Fyn. Mol Cell Biol 2000; 20:1426-1435. (Pubitemid 30069262)
48. Dong S, Corre B, Nika K, et al. T cell receptor signal initiation induced by lowgrade stimulation requires the cooperation of LAT in human T cells. PLoSOne 2010; 5:e15114.
49. Martinez-Florensa M, Garcia-Blesa A, Yelamos J, et al. Serine residues in the LAT adaptor are essential for TCR-dependent signal transduction. J Leukoc Biol 2011; 89:63-73.
50. Wang H, Kadlecek TA, Au-Yeung BB, et al. ZAP-70: an essential kinase in T-cell signaling. Cold Spring Harb Perspect Biol 2010; 2:a002279.
51. Bueno C, Lemke CD, Criado G, et al. Bacterial superantigens bypass Lckdependent T cell receptor signaling by activating a Galpha11-dependent, PLC-beta-mediated pathway. Immunity 2006; 25:67-78. (Pubitemid 44066827)
52. Huang Y, Wange RL. T cell receptor signaling: beyond complex complexes. J Biol Chem 2004; 279:28827-28830. (Pubitemid 38915748)
53. Paiardini M, Pandrea I, Apetrei C, Silvestri G. Lessons learned from the natural hosts of HIV-related viruses. Annu Rev Med 2009; 60:485-495.
54. Wain LV, Bailes E, Bibollet-Ruche F, et al. Adaptation of HIV-1 to its human host. Mol Biol Evol 2007; 24:1853-1860. (Pubitemid 47236708)
55. Hahn BH, Shaw GM, De Cock KM, Sharp PM. AIDS as a zoonosis: scientific and public health implications. Science 2000; 287:607-614. (Pubitemid 30070900)
56. Sharp PM, Hahn BH. The evolution of HIV-1 and the origin of AIDS. Philos Trans R Soc Lond B Biol Sci 2010; 365:2487-2494.
57. Letvin NL, Daniel MD, Sehgal PK, et al. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 1985; 230:71-73. (Pubitemid 16221618)
58. Kanki PJ, McLane MF, King NW Jr, et al. Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science 1985; 228:1199-1201. (Pubitemid 15232891)
59. Klatt NR, Villinger F, Bostik P, et al. Availability of activated CD4 T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys. J Clin Invest 2008; 118:2039-2049. (Pubitemid 351872324)
60. Meythaler M, Martinot A, Wang Z, et al. Differential CD4 T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection. J Virol 2009; 83:572-583.
61. Milush JM, Reeves JD, Gordon SN, et al. Virally induced CD4 T cell depletion is not sufficient to induce AIDS in a natural host. J Immunol 2007; 179:3047-3056.
62. Dunham R, Pagliardini P, Gordon S, et al. The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus. Blood 2006; 108:209-217. (Pubitemid 43990631)
63. Kouyos RD, Gordon SN, Staprans SI, et al. Similar impact of CD8 T cell responses on early virus dynamics during SIV infections of rhesus macaques and sooty mangabeys. PLoS Comput Biol 2010; 6:.
64. Li B, Stefano-Cole K, Kuhrt DM, et al. Nonpathogenic simian immunodeficiency virus infection of sooty mangabeys is not associated with high levels of autologous neutralizing antibodies. J Virol 2010; 84:6248-6253.
65. Estes JD, Gordon SN, Zeng M, et al. Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques. J Immunol 2008; 180:6798-6807.
66. Bosinger SE, Sodora DL, Silvestri G. Generalized immune activation and innate immune responses in simian immunodeficiency virus infection. Curr Opin HIV AIDS 2011; 6:411-418.
67. Bosinger SE, Li Q, Gordon SN, et al. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 2009; 119:3556-3572.
68. Rout N, Else JG, Yue S, et al. Heterogeneity in phenotype and function of CD8 and CD4/CD8 double-negative Natural Killer T cell subsets in sooty mangabeys. J Med Primatol 2010; 39:224-234.
69. Veazey RS, Rosenzweig M, Shvetz DE, et al. Characterization of gut-associated lymphoid tissue (GALT) of normal rhesus macaques. Clin Immunol Immunopathol 1997; 82:230-242. (Pubitemid 27128309)
70. Veazey RS, DeMaria M, Chalifoux LV, et al. Gastrointestinal tract as a major site of CD4 T cell depletion and viral replication in SIV infection. Science 1998; 280:427-431. (Pubitemid 28208163)
71. Mathiot ND, Krueger R, French MA, Price P. Percentage of CD3CD4-CD8- gammadeltaTCR- T cells is increased HIV disease. AIDS Res Hum Retroviruses 2001; 17:977-980.
72. Petitjean G, Chevalier MF, Tibaoui F, et al. Level of double negative T cells, which produce TGF-beta and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection. AIDS 2011. This study indicates the potential regulatory role of double-negative T cells during primary HIV-1 infection and their potential to predict future immune activation in these patients.
73. Cheney KM, Kumar R, Purins A, et al. HIV type 1 persistence in CD4-/CD8- double negative T cells from patients on antiretroviral therapy. AIDS Res Hum Retroviruses 2006; 22:66-75. (Pubitemid 43201520)
74. Kaiser P, Joos B, Niederost B, et al. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes. J Virol 2007; 81:9693-9706. (Pubitemid 350067674)
75. Marodon G, Warren D, Filomio MC, Posnett DN. Productive infection of double-negative T cells with HIV in vivo. Proc Natl Acad Sci U S A 1999; 96:11958-11963. (Pubitemid 29502840)
76. Fry TJ, Moniuszko M, Creekmore S, et al. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 2003; 101:2294-2299. (Pubitemid 36302072)
77. Chahroudi A, Silvestri G. Interleukin-7 in HIV pathogenesis and therapy. Eur Cytokine Netw 2010; 21:202-207.
78. Catalfamo M, Wilhelm C, Tcheung L, et al. CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7. J Immunol 2011; 186:2106-2116.
79. Camargo JF, Kulkarni H, Agan BK, et al. Responsiveness of T cells to interleukin-7 is associated with higher CD4 T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression. J Infect Dis 2009; 199:1872-1882.
80. Sereti I, Dunham RM, Spritzler J, et al. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 2009; 113:6304-6314.
81. Levy Y, Lacabaratz C, Weiss L, et al. Enhanced T cell recovery in HIV-1- infected adults through IL-7 treatment. J Clin Invest 2009; 119:997-1007.
82. Lecuroux C, Girault I, Boutboul F, et al. Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8 T cells. AIDS 2009; 23:1649-1658.
83. Beq S, Nugeyre MT, Ho Tsong Fang R, et al. IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy. J Immunol 2006; 176:914-922. (Pubitemid 43099689)
84. Dereuddre-Bosquet N, Vaslin B, Delache B, et al. Rapid modifications of peripheral T-cell subsets that express CD127 in macaques treated with recombinant IL-7. J Med Primatol 2007; 36:228-237. (Pubitemid 47103486)
85. Leone A, Picker LJ, Sodora DL. IL-2, IL-7 and IL-15 as immunomodulators during SIV/HIV vaccination and treatment. Curr HIV Res 2009; 7:83-90.
86. Leone A, Rohankhedkar M, Okoye A, et al. Increased CD4 T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses. J Immunol 2010; 185:1650-1659.
87. Lu H, Zhao Z, Kalina T, et al. Interleukin-7 improves reconstitution of antiviral CD4 T cells. Clin Immunol 2005; 114:30-41. (Pubitemid 39642788)
88. Moniuszko M, Fry T, Tsai WP, et al. Recombinant interleukin-7 induces proliferation of naive macaque CD4 and CD8 T cells in vivo. J Virol 2004; 78:9740-9749. (Pubitemid 39187092)
89. Nugeyre MT, Monceaux V, Beq S, et al. IL-7 stimulates T cell renewal without increasing viral replication in simian immunodeficiency virus-infected macaques. J Immunol 2003; 171:4447-4453. (Pubitemid 37238725)
90. Abrams D, Levy Y, Losso MH, et al. Interleukin-2 therapy in patients with HIV infection. New Engl J Med 2009; 361:1548-1559.
91. Davey RT Jr, Chaitt DG, Albert JM, et al. A randomized trial of high- versus lowdose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection. J Infect Dis 1999; 179:849-858. (Pubitemid 29159330)
92. Eberly MD, Kader M, Hassan W, et al. Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to simian immunodeficiency virus during acute infection. J Immunol 2009; 182:1439-1448.
93. Rosenthal R, Groeper C, Bracci L, et al. Differential responsiveness to IL-2, IL-7, and IL-15 common receptor gamma chain cytokines by antigen-specific peripheral blood naive or memory cytotoxic CD8 T cells from healthy donors and melanoma patients. J Immunother 2009; 32:252-261